-+ 0.00%
-+ 0.00%
-+ 0.00%

Zenas BioPharma to host virtual R&D event on pipeline updates

PUBT·10/06/2026 11:07:23
Zenas BioPharma to host virtual R&D event on pipeline updates
  • Zenas BioPharma will host a virtual R&D event on Oct. 27, 2026, from 8:00 a.m. to 9:30 a.m. ET.
  • Management will outline the R&D pipeline, with a focus on obexelimab in systemic lupus erythematosus.
  • Updates will also cover development of ZB021, an oral IL-17AA/AF inhibitor.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zenas Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610060705PRIMZONEFULLFEED9840230) on October 06, 2026, and is solely responsible for the information contained therein.